Fluorouracil, Doxorubicin, and Cyclophosphamide (FAC) Versus FAC Followed by Weekly Paclitaxel As Adjuvant Therapy for High-Risk, Node-Negative Breast Cancer: Results From the GEICAM/2003-02 Study
MARTIN, Miguel, RUIZ, Amparo, MUNOZ-MATEU, Montserrat, DORCA RIBUGENT, Joan, LOPEZ-VEGA, José Manuel, JARA, Carlos, ESPINOSA, Enrique, MENDIOLA FERNANDEZ, César, ANDRES, Raquel, RIBELLES, Nuria, PLAZAOLA, Arrate, SANCHEZ-ROVIRA, Pedro, RUIZ BORREGO, Manuel, SALVADOR BOFILL, Javier, CRESPO, Carmen, CARABANTES, Francisco J, SERVITJA, Sonia, IGNACIO CHACON, José, RODRIGUEZ, César A, HERNANDO, Blanca, ALVAREZ, Isabel, CARRASCO, Eva, LLUCH, Ana, BARNADAS, Agustí, GONZALEZ, Sonia, CALVO, Lourdes, MARGELI VILA, Mireia, ANTON, Antonio, RODRIGUEZ-LESCURE, Alvaro, SEGUI-PALMER, Miguel Angel
Published in Journal of clinical oncology (10.07.2013)
Published in Journal of clinical oncology (10.07.2013)
Get full text
Journal Article
Abstract CT154: Multicenter open-label, phase II trial, to evaluate the efficacy and safety of liposomal irinotecan (nal-IRI) for progressing brain metastases in patients with HER2-negative breast cancer (The Phenomenal Study)
Cortés, Javier, Paez, David, García, José Manuel Pérez, Tormo, Salvador Blanch, Parraga, Kepa Amillano, Borrego, Manuel Ruiz, Torres, Antonio Antón, Fernández, María, Conejo, Emilio Alba, Palmer, Miguel Ángel Seguí, Ribugent, Joan Dorca, López López, Rafael, Vila, Mireia Margelí, Aguirre, Elena, Llombart, Antonio
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
First safety results of an international phase II study evaluating oral vinorelbine as a single agent as first-line chemotherapy for metastatic breast cancer patients with bone metastases (NorBreast-228 trial)
Steger, Guenther G., Dobrovolskaya, Natalya, Dominguez, Adriana, Switsers, Odile, Giotta, Francesco, Glogowska, Iwona, Tubiana-Mathieu, Nicole, Pecherstorfer, Martin, Ardizzoia, Andrea, Bougnoux, Philippe, Blasinska-Morawiec, Maria, Veyret, Corinne, Garcia, Sheyla, Dorca Ribugent, Joan, Marth, Christian, Manikhas, Alexey, Benasso, Marco, Protsenko, Svetlana, Villanova, Gustavo, Espinosa, Enrique
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Randomized phase III study of adjuvant chemotherapy for high-risk, node-negative breast cancer (BC) comparing FAC with FAC followed by weekly paclitaxel: First efficacy analysis of the GEICAM/2003-02 trial
Martin, Miguel, Lluch, Ana, Ruiz, Amparo, Ruiz Borrego, Manuel, Barnadas, Agust, Gonzalez, Sonia, Calvo, Lourdes, Margeli Vila, Mireia, Anton, Antonio, Rodriguez-Lescure, Alvaro, Seguí-Palmer, Miguel Angel, Munoz-Mateu, Montserrat, Dorca Ribugent, Joan, Lopez-Vega, Jose Manuel, Mendiola Fernandez, Cesar, Andres, Raquel, Plazaola, Arrate, Rodriguez, Cesar, Casas, Maria Isabel, Carrasco, Eva Maria
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts
Cufi, Silvia, Corominas-Faja, Bruna, Vazquez-Martin, Alejandro, Oliveras-Ferraros, Christina, Dorca, Joan, Bosch-Barrera, Joaquim, Martin-Castillo, Begoña, Menendez, Javier A
Published in Oncotarget (01.04.2012)
Published in Oncotarget (01.04.2012)
Get full text
Journal Article